Rosa D’agostino

Rosa D’Agostino works in the adenoviral team developing vaccines targeting infectious diseases and cancer.

She joined SpyBiotech in June 2023 from Exact Sciences Innovation in Oxford, where she worked in the development of novel NGS tools for use in the arenas of epigenetics and cancer diagnostics.

Prior to this, Rosa worked in the Protein Science Pipeline at Immunocore LTD where she was involved in the advancement of the company pipeline (unique platform of T cell receptor-based therapeutics, called ImmTAXs). Rosa moved to the UK in 2016 after having obtained a Master’s degree in Molecular Biology and Genetics from the University of Pavia, Italy. Prior to this, she obtained a Bachelor Degree in Biology from the University of Naples, Federico II, Italy.